Quarterly report [Sections 13 or 15(d)]

Note 8 - Common Stock Warrant Liabilities

v3.25.1
Note 8 - Common Stock Warrant Liabilities
3 Months Ended
Mar. 31, 2025
Notes to Financial Statements  
Common Stock Warrant Liabilities [Text Block]

Note 8 - Common Stock Warrants

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each consolidated balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a gain or loss on the condensed consolidated statements of operations.

 

Warrant Liability

 

The Company has previously issued freestanding warrants to purchase shares of its common stock in connection with financing activities. The outstanding warrants to purchase common stock originally issued by the Company in October 2022 (the "October 2022 Warrants") are classified as liabilities on the balance sheet as they contain terms for redemption of the underlying security that are outside the Company's control. The previously outstanding warrants to purchase common stock originally issued by the Company in January 2023 (the "January 2023 Warrants") classified as liabilities were fully exercised during the three months ended March 31, 2024. The Black-Scholes Model is used to value the warrants classified as liabilities and the approach required management to estimate inputs including expected volatility and expected term and is most significantly impacted by the volatility of the Company's common stock price. These inputs are inherently subjective and require significant analysis and judgment to develop. 

 

The fair value of the warrants was measured at the time of issuance and is re-measured at each financial reporting date with any changes in fair value being recognized in change in fair value of warrant liabilities, a component of other income (expense), in the consolidated statements of operations and comprehensive income (loss). The Company will continue to re-measure the fair value of the  October 2022 Warrant liabilities until exercise or expiration of the warrants on  October 10, 2027.

 

Fair Value of Warrant Liabilities

 

Warrant liabilities are categorized within Level 3 of the fair value hierarchy and are measured at fair value on a recurring basis as follows (in thousands):

 

 

   

October 2022

 
   

Warrants

 

Fair value of warrants outstanding as of December 31, 2024

  $ 16  

Change in fair value of warrants

    (15 )

Fair value of warrants outstanding as of March 31, 2025

  $ 1  

 

The key inputs for the  October 2022 Warrants using the Black-Scholes model were as follows:

 

 

   

March 31,

   

December 31,

 
   

2025

   

2024

 

Stock price

  $ 0.30     $ 2.00  

Risk-free interest rate

    4.35 %     4.27 %

Expected dividend yield

           

Expected term in years

    2.5       2.8  

Expected volatility

    160 %     155 %